Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Chlorthalidone measurement |
Component |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Allergy to chlortalidone |
Causative agent (attribute) |
False |
Chlortalidone |
Inferred relationship |
Some |
|
Chlortalidone 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
|
Chlorthalidone 25mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
|
Chlorthalidone 50mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
|
Chlortalidone 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
|
Chlortalidone 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
|
Chlortalidone 15 mg and clonidine hydrochloride 200 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
|
Product containing precisely chlortalidone 15 milligram and clonidine hydrochloride 300 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
|
Product containing chlortalidone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
|
Atenolol 100 mg and chlortalidone 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
|
Atenolol 50 mg and chlortalidone 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
|
Product containing chlortalidone and triamterene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
2 |
Product containing chlortalidone and clonidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
|
Product containing atenolol and chlortalidone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Chlorthalidone adverse reaction |
Causative agent (attribute) |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Atenolol 50 mg and chlortalidone 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
|
Allergy to chlortalidone |
Causative agent (attribute) |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Atenolol 50 mg and chlortalidone 12.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Atenolol 50 mg and chlortalidone 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Chlortalidone 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
1 |
Chlortalidone 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Atenolol 50 mg and chlortalidone 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
2 |
Atenolol 50 mg and chlortalidone 12.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Chlortalidone |
Inferred relationship |
Some |
2 |
Chlortalidone 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
1 |
Chlortalidone 15 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Chlortalidone 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
1 |
Chlortalidone 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Atenolol 100 mg and chlortalidone 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
1 |
Atenolol 100 mg and chlortalidone 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Product containing precisely chlortalidone 15 milligram and clonidine hydrochloride 300 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlortalidone |
Inferred relationship |
Some |
2 |
Atenolol 50 mg and chlortalidone 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
2 |
Atenolol 50 mg and chlortalidone 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Chlortalidone |
Inferred relationship |
Some |
2 |
Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
1 |
Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Chlortalidone |
Inferred relationship |
Some |
1 |
Product containing precisely chlortalidone 15 milligram and clonidine hydrochloride 300 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
1 |
Product containing precisely chlortalidone 15 milligram and clonidine hydrochloride 300 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Chlortalidone |
Inferred relationship |
Some |
1 |
Chlortalidone 15 mg and clonidine hydrochloride 200 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
1 |
Chlortalidone 15 mg and clonidine hydrochloride 200 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Chlortalidone |
Inferred relationship |
Some |
1 |
Chlortalidone 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Product containing precisely chlortalidone 15 milligram and clonidine hydrochloride 300 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlortalidone |
Inferred relationship |
Some |
2 |
Chlortalidone 15 mg and clonidine hydrochloride 200 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Chlortalidone |
Inferred relationship |
Some |
1 |
Chlortalidone 25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Chlortalidone 15 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Atenolol- and chlortalidone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Atenolol 50 mg and chlortalidone 25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Product containing chlortalidone and clonidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
2 |
Atenolol 50 mg and chlortalidone 12.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Chlortalidone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Chlortalidone- and clonidine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
2 |
Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Chlortalidone |
Inferred relationship |
Some |
1 |
Atenolol 100 mg and chlortalidone 25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Product containing chlortalidone and triamterene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
2 |
Chlortalidone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Chlortalidone and clonidine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
2 |
Chlortalidone and triamterene only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
2 |
Product containing only atenolol and chlortalidone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Chlortalidone and clonidine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
2 |
Chlortalidone and triamterene only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
2 |
Chlortalidone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Atenolol and chlortalidone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlortalidone |
Inferred relationship |
Some |
2 |
Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlortalidone |
Inferred relationship |
Some |
2 |
Chlortalidone 15 mg and clonidine hydrochloride 200 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlortalidone |
Inferred relationship |
Some |
2 |
Chlortalidone 15 mg and clonidine hydrochloride 200 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlortalidone |
Inferred relationship |
Some |
2 |
Product containing precisely chlortalidone 6.25 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Product containing precisely chlortalidone 6.25 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Product containing chlortalidone and telmisartan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
2 |
Chlortalidone- and telmisartan-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
2 |
Product containing only chlortalidone and telmisartan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
2 |
Product containing only chlortalidone and telmisartan in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
2 |
Chlortalidone 12.5 mg and telmisartan 40 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlortalidone |
Inferred relationship |
Some |
2 |
Chlortalidone 12.5 mg and telmisartan 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlortalidone |
Inferred relationship |
Some |
2 |
Product containing precisely chlortalidone 6.25 milligram and telmisartan 40 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlortalidone |
Inferred relationship |
Some |
2 |
Product containing precisely chlortalidone 6.25 milligram and telmisartan 40 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlortalidone |
Inferred relationship |
Some |
2 |
Chlortalidone 12.5 mg and olmesartan medoxomil 40 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Chlortalidone 12.5 mg and olmesartan medoxomil 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Product containing chlortalidone and olmesartan medoxomil in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
1 |
Product containing only chlortalidone and olmesartan medoxomil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
1 |
Product containing chlortalidone and olmesartan medoxomil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
1 |
Product containing only chlortalidone and olmesartan medoxomil in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlortalidone |
Inferred relationship |
Some |
1 |
Product containing only chlortalidone and olmesartan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Product containing chlortalidone and olmesartan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Chlortalidone and olmesartan only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |
Product containing chlortalidone and olmesartan in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlortalidone |
Inferred relationship |
Some |
1 |